Join BJS Academy
BJS Academy>Randomized clinical ...>Total pancreatectomy...
Normal View Dyslexic View

Total pancreatectomy with islet autotransplantation as an alternative to high-risk pancreatojejunostomy after pancreaticoduodenectomy. A prospective randomized trial.

7 September 2023
Randomized clinical trials HPB
Balzano G, Zerbi A, Aleotti F, Capretti G, Melzi R, Pecorelli N et al.

Ann Surg 2023; 277: 894-903.

Total pancreatectomy (TP) was associated with reduced perioperative morbidity: 60 versus 90.3%, P=0.008, and similar hospital stay, in this study that included 61 procedures. Survival rates were also similar, but TP was associated with a higher risk of diabetes.

Comment: Intriguing, and could lead to a change in standard care.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct090
Randomized clinical trials
Randomized clinical trials
HPB
Total pancreatectomy with islet autotransplantation as an alternative to high-risk pancreatojejunostomy after pancreaticoduodenectomy. A prospective randomized trial.
Balzano G, Zerbi A, Aleotti F, Capretti G, Melzi R, Pecorelli N et al.
07092023
Ann Surg 2023; 277: 894-903.
Total pancreatectomy (TP) was associated with reduced perioperative morbidity: 60 versus 90.3%, P=0.008, and similar hospital stay, in this study that included 61 procedures. Survival rates were also similar, but TP was associated with a higher risk of diabetes.
Comment: Intriguing, and could lead to a change in standard care.
Published on: 7 September 2023
Article ID: rct090

Related articles

Temporary portocaval shunt provides superior intraoperative hemodynamics and reduces blood loss and duration of surgery in live donor liver transplantation. A randomized controlled trial.

Kumar M, Patil NS, Mohapatra N, Sindwani G, Dhingra U, Yadav A et al.
Ann Surg 2024; 279: 932-944.

16 August 2024

Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!